Governance

The Management Committee

Rare Disease UK is overseen by the management committee who meet monthly. The following people are members of the management committee:

• Alastair Kent - Director of the Genetic Interest Group (RDUK Chair)
• Steve Potter - Therapy Liaison Manager, Genzyme Therapeutics (RDUK Treasurer)
• Becky Purvis - Policy and Public Affairs Manager - Association of Medical Research Charities (RDUK Secretary)
• Dr Peter Corry - Paediatrician, Bradford
• Julie-Ann Bridge - Chair of the Orphan Disease Industry Group
• Marita Pohlschmidt - Head of Research, Muscular Dystrophy Campaign
• Laura Gilbert - Freelance Research Consultant
• Dr Stephen Jolles - Clinical Immunologist, University of Wales Hospital Cardiff (Advisor for Wales)
• Marie McGill - National Lead, Single Gene Complex Need Project (SGCN), Western General Hospital, Edinburgh (Advisor for Scotland)
• Dr Fiona Stewart - Consultant in Medical Genetics, Belfast City Hospital (Advisor for Northern Ireland)

Genetic Interest Group staff working on RDUK

• Stephen Nutt -  RDUK Secretariat:
  Email: stephenraredisease.org.uk
• Melissa Hillier - RDUK Communications:
  Email: melissararedisease.org.uk
• Buddug Williams - RDUK in Wales:
  Email: williamsbgcardiff.ac.uk
• Claire Cotterill - RDUK in Scotland:
  Email: clairegig.org.uk

Constitution

A copy of the RDUK constitution can be downloaded here.

Funding

Rare Disease UK is funded by a subscription from pharmaceutical industry members. The amount paid by each company is £7,000 per annum.